Aetna policies
Search Aetna's public medical, payment and drug policies by CPT or HCPCS code, keyword or policy number, with links to the payer's own documents. Links open the payer's own document; check its current version before relying on it.
Checking prior authorization for J3380? Open Aetna’s official lists and confirm the member’s product there.
8 policies name J3380, those listing the fewest codes first. A policy that names a code may also list it as excluded.
| Policy | Details | Codes | Source |
|---|---|---|---|
| 1091-Therapeutic Drug Monitoring of Anti-Tumor Necrosis Factor Blocking Agents | 1091 · Commercial | 23 | Original policy ↗ |
| 0732-Guillain-Barre Syndrome Treatments | 0732 · Commercial | 43 | Original policy ↗ |
| 0885-Vedolizumab (Entyvio) | 0885 · Commercial | 52 | Original policy ↗ |
| 0912-Ustekinumab | 0912 · Commercial | 61 | Original policy ↗ |
| 1009-Risankizumab-rzaa (Skyrizi) | 1009 · Commercial | 66 | Original policy ↗ |
| Polymerase Chain Reaction Testing: Selected Indications | 0650 · Commercial | 182 | Original policy ↗ |
| Participating provider precertification list for Aetna® | 1013000-01-35 · Effective Nov 1, 2025 · Commercial | 1,389 | Original policy ↗ |
| Participating provider precertification list for Aetna® | Effective Jan 1, 2026 · Commercial | 1,440 | Original policy ↗ |